Natalia Igorevna Palacios, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 13 | 2023 | 2896 | 2.460 |
Why?
|
| Diet, Mediterranean | 3 | 2023 | 748 | 1.100 |
Why?
|
| Metabolomics | 2 | 2024 | 1675 | 0.930 |
Why?
|
| Carnitine | 1 | 2024 | 253 | 0.840 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2023 | 119 | 0.790 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2023 | 217 | 0.740 |
Why?
|
| Proton Pump Inhibitors | 2 | 2023 | 553 | 0.740 |
Why?
|
| Environmental Exposure | 4 | 2017 | 4538 | 0.730 |
Why?
|
| Depression | 4 | 2024 | 8240 | 0.640 |
Why?
|
| Puerto Rico | 4 | 2024 | 380 | 0.630 |
Why?
|
| Air Pollutants | 4 | 2017 | 2905 | 0.620 |
Why?
|
| Air Pollution | 3 | 2017 | 2367 | 0.610 |
Why?
|
| Vitamin B 6 | 1 | 2019 | 237 | 0.590 |
Why?
|
| Caffeine | 2 | 2012 | 703 | 0.540 |
Why?
|
| Particulate Matter | 3 | 2017 | 2607 | 0.520 |
Why?
|
| Vitamin D | 2 | 2020 | 3311 | 0.520 |
Why?
|
| Cognition | 5 | 2023 | 7080 | 0.520 |
Why?
|
| Metformin | 1 | 2023 | 909 | 0.500 |
Why?
|
| Sex Characteristics | 2 | 2018 | 2660 | 0.490 |
Why?
|
| Appendectomy | 1 | 2018 | 443 | 0.480 |
Why?
|
| Risk | 4 | 2021 | 9621 | 0.460 |
Why?
|
| Boston | 7 | 2024 | 9375 | 0.420 |
Why?
|
| Metals, Heavy | 1 | 2014 | 149 | 0.420 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 5892 | 0.400 |
Why?
|
| Skin Diseases | 1 | 2021 | 1085 | 0.400 |
Why?
|
| Coffee | 2 | 2012 | 594 | 0.370 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 1388 | 0.370 |
Why?
|
| Particle Size | 1 | 2014 | 1652 | 0.350 |
Why?
|
| Cohort Studies | 12 | 2024 | 41800 | 0.320 |
Why?
|
| Veterans | 1 | 2023 | 2672 | 0.320 |
Why?
|
| Achievement | 1 | 2008 | 288 | 0.270 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 12563 | 0.250 |
Why?
|
| Reading | 1 | 2008 | 543 | 0.240 |
Why?
|
| Middle Aged | 20 | 2024 | 223740 | 0.220 |
Why?
|
| Aged | 17 | 2024 | 171790 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 1182 | 0.220 |
Why?
|
| Zea mays | 3 | 2013 | 109 | 0.210 |
Why?
|
| Humans | 35 | 2024 | 768887 | 0.200 |
Why?
|
| Female | 25 | 2024 | 397464 | 0.200 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8758 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 12252 | 0.200 |
Why?
|
| Histamine H2 Antagonists | 1 | 2023 | 169 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 551 | 0.190 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2252 | 0.190 |
Why?
|
| Histamine | 1 | 2023 | 496 | 0.190 |
Why?
|
| Male | 21 | 2024 | 365249 | 0.170 |
Why?
|
| Vitamin B 12 | 1 | 2023 | 528 | 0.170 |
Why?
|
| Risk Factors | 10 | 2023 | 74971 | 0.170 |
Why?
|
| Case-Control Studies | 4 | 2023 | 22294 | 0.170 |
Why?
|
| Obesity | 2 | 2013 | 13087 | 0.170 |
Why?
|
| Metagenomics | 1 | 2023 | 474 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 4045 | 0.160 |
Why?
|
| Self Report | 2 | 2023 | 3773 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 26384 | 0.150 |
Why?
|
| Smoking | 2 | 2012 | 9094 | 0.140 |
Why?
|
| Life Style | 2 | 2023 | 3931 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2021 | 708 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3250 | 0.130 |
Why?
|
| Incidence | 4 | 2018 | 21545 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2011 | 2280 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 39394 | 0.120 |
Why?
|
| Food Supply | 1 | 2020 | 544 | 0.120 |
Why?
|
| Nutritional Status | 2 | 2012 | 1627 | 0.110 |
Why?
|
| Sex Factors | 3 | 2012 | 10641 | 0.110 |
Why?
|
| Seeds | 1 | 2013 | 124 | 0.110 |
Why?
|
| Carotenoids | 2 | 2013 | 620 | 0.110 |
Why?
|
| Educational Status | 2 | 2012 | 2515 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2023 | 2701 | 0.100 |
Why?
|
| Arabidopsis | 2 | 2006 | 469 | 0.100 |
Why?
|
| Beer | 1 | 2012 | 135 | 0.100 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 2189 | 0.100 |
Why?
|
| Wine | 1 | 2012 | 172 | 0.100 |
Why?
|
| Adult | 9 | 2024 | 223818 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1466 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 14795 | 0.090 |
Why?
|
| Arsenic | 1 | 2014 | 358 | 0.090 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 7860 | 0.090 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 3837 | 0.090 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 266 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2024 | 54950 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 3110 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 16051 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2010 | 68 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1405 | 0.090 |
Why?
|
| Quality of Life | 1 | 2012 | 13510 | 0.090 |
Why?
|
| Diet | 2 | 2022 | 8090 | 0.080 |
Why?
|
| Nurses | 2 | 2021 | 2501 | 0.080 |
Why?
|
| Intestinal Absorption | 1 | 2010 | 400 | 0.080 |
Why?
|
| Memory | 1 | 2019 | 2210 | 0.080 |
Why?
|
| Denmark | 1 | 2011 | 778 | 0.080 |
Why?
|
| beta Carotene | 1 | 2010 | 523 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 18065 | 0.070 |
Why?
|
| Comorbidity | 2 | 2021 | 10591 | 0.070 |
Why?
|
| Multilingualism | 1 | 2008 | 88 | 0.070 |
Why?
|
| Restless Legs Syndrome | 1 | 2011 | 235 | 0.070 |
Why?
|
| Vitamin A | 1 | 2010 | 611 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 59738 | 0.070 |
Why?
|
| Beverages | 1 | 2012 | 819 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7148 | 0.070 |
Why?
|
| Anthropometry | 1 | 2011 | 1343 | 0.070 |
Why?
|
| Arabidopsis Proteins | 2 | 2006 | 264 | 0.070 |
Why?
|
| Canada | 1 | 2011 | 2129 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2012 | 1129 | 0.060 |
Why?
|
| United States | 4 | 2014 | 73180 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15955 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 1209 | 0.050 |
Why?
|
| Social Environment | 1 | 2008 | 1016 | 0.050 |
Why?
|
| Solanum tuberosum | 1 | 2003 | 47 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 254 | 0.050 |
Why?
|
| Hexokinase | 1 | 2003 | 124 | 0.050 |
Why?
|
| Carbon | 1 | 2006 | 672 | 0.050 |
Why?
|
| Sucrose | 1 | 2003 | 158 | 0.050 |
Why?
|
| Parenting | 1 | 2008 | 709 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8615 | 0.050 |
Why?
|
| Genes, Plant | 2 | 2013 | 129 | 0.050 |
Why?
|
| Biological Assay | 1 | 2004 | 628 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4055 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 232 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2003 | 242 | 0.050 |
Why?
|
| Linear Models | 1 | 2011 | 5890 | 0.050 |
Why?
|
| Massachusetts | 2 | 2024 | 8888 | 0.050 |
Why?
|
| Prescriptions | 1 | 2023 | 388 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 395 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2013 | 6610 | 0.040 |
Why?
|
| Mothers | 1 | 2011 | 2211 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4251 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 703 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2004 | 783 | 0.040 |
Why?
|
| Robotics | 1 | 2004 | 826 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2004 | 1093 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 3743 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15471 | 0.030 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 2133 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 13054 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 2593 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2012 | 81892 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 138 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 752 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 18454 | 0.020 |
Why?
|
| Plants, Genetically Modified | 2 | 2003 | 115 | 0.020 |
Why?
|
| Glucose | 1 | 2003 | 4352 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2013 | 4624 | 0.020 |
Why?
|
| Manihot | 1 | 2010 | 4 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2013 | 540 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 948 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 40266 | 0.020 |
Why?
|
| Biological Availability | 1 | 2010 | 392 | 0.020 |
Why?
|
| Food, Fortified | 1 | 2010 | 189 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2010 | 265 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2008 | 42684 | 0.020 |
Why?
|
| Chlorophyll | 1 | 2006 | 30 | 0.020 |
Why?
|
| Starch | 1 | 2006 | 81 | 0.020 |
Why?
|
| Biomass | 1 | 2006 | 131 | 0.020 |
Why?
|
| Photoperiod | 1 | 2006 | 141 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2006 | 262 | 0.020 |
Why?
|
| Nitrate Reductases | 1 | 2004 | 7 | 0.020 |
Why?
|
| Nitrate Reductase | 1 | 2004 | 11 | 0.020 |
Why?
|
| Nitrates | 1 | 2006 | 260 | 0.020 |
Why?
|
| Phosphorylases | 1 | 2004 | 17 | 0.020 |
Why?
|
| Nitrogen | 1 | 2006 | 345 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2931 | 0.020 |
Why?
|
| Darkness | 1 | 2004 | 160 | 0.010 |
Why?
|
| Venezuela | 1 | 2004 | 73 | 0.010 |
Why?
|
| Glucose-1-Phosphate Adenylyltransferase | 1 | 2003 | 1 | 0.010 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2004 | 211 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 126 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 600 | 0.010 |
Why?
|
| Myosins | 1 | 2004 | 408 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 17629 | 0.010 |
Why?
|
| Decision Trees | 1 | 2004 | 509 | 0.010 |
Why?
|
| Phenols | 1 | 2006 | 523 | 0.010 |
Why?
|
| Child | 2 | 2008 | 80969 | 0.010 |
Why?
|
| Consanguinity | 1 | 2004 | 460 | 0.010 |
Why?
|
| Light | 1 | 2006 | 1356 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1716 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 23652 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 1169 | 0.010 |
Why?
|
| Caulimovirus | 1 | 1999 | 3 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1999 | 194 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9682 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3274 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 1057 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3588 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 7602 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2226 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 1966 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4545 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13317 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 901 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6085 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Plasmids | 1 | 1999 | 2269 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1999 | 1148 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2004 | 2905 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 2205 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 13048 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7609 | 0.010 |
Why?
|
| DNA Repair | 1 | 1999 | 2054 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 12430 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 5801 | 0.000 |
Why?
|
| Infant | 1 | 2004 | 36541 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 30266 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 89247 | 0.000 |
Why?
|